BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37936677)

  • 1. Improved Leukemia Clearance After Adoptive Transfer of NK Cells Expressing the Bone Marrow Homing Receptor CXCR4
    Segerberg F; Lambert M; Sanz-Ortega L; Andersson A; Childs RW; Carlsten M
    Hemasphere; 2023 Nov; 7(11):e974. PubMed ID: 37936677
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4
    Levy E; Reger R; Segerberg F; Lambert M; Leijonhufvud C; Baumer Y; Carlsten M; Childs R
    Front Immunol; 2019; 10():1262. PubMed ID: 31231387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control.
    Grzywacz B; Moench L; McKenna D; Tessier KM; Bachanova V; Cooley S; Miller JS; Courville EL
    J Immunother; 2019; 42(2):65-72. PubMed ID: 30489431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells.
    Bonanni V; Antonangeli F; Santoni A; Bernardini G
    J Immunother Cancer; 2019 Nov; 7(1):290. PubMed ID: 31699153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice.
    Beider K; Nagler A; Wald O; Franitza S; Dagan-Berger M; Wald H; Giladi H; Brocke S; Hanna J; Mandelboim O; Darash-Yahana M; Galun E; Peled A
    Blood; 2003 Sep; 102(6):1951-8. PubMed ID: 12730102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.
    Cany J; van der Waart AB; Tordoir M; Franssen GM; Hangalapura BN; de Vries J; Boerman O; Schaap N; van der Voort R; Spanholtz J; Dolstra H
    PLoS One; 2013; 8(6):e64384. PubMed ID: 23755121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome.
    McDermott DH; Lopez J; Deng F; Liu Q; Ojode T; Chen H; Ulrick J; Kwatemaa N; Kelly C; Anaya-O'Brien S; Garofalo M; Marquesen M; Hilligoss D; DeCastro R; Malech HL; Murphy PM
    J Cell Mol Med; 2011 Oct; 15(10):2071-81. PubMed ID: 21070597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced recruitment and hematopoietic reconstitution of bone marrow-derived mesenchymal stem cells in bone marrow failure by the SDF-1/CXCR4.
    Chen L; Li Y; Chen W; Han N; Li K; Guo R; Liu Z; Xiao Y
    J Tissue Eng Regen Med; 2020 Sep; 14(9):1250-1260. PubMed ID: 32633015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells.
    Chen W; Li M; Cheng H; Yan Z; Cao J; Pan B; Sang W; Wu Q; Zeng L; Li Z; Xu K
    Cell Biochem Biophys; 2013; 67(3):1181-91. PubMed ID: 23712865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Over-expression of CXCR4 promotes homing and proliferation of mouse bone marrow mesenchymal stem cells].
    Wang Z; Lin Y; Ye H; Chen W; Shang J; Wei T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):393-398. PubMed ID: 31223107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target.
    Burger JA; Bürkle A
    Br J Haematol; 2007 May; 137(4):288-96. PubMed ID: 17456052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 and CCR5 mediate homing of primitive bone marrow-derived hematopoietic cells to the postnatal thymus.
    Robertson P; Means TK; Luster AD; Scadden DT
    Exp Hematol; 2006 Mar; 34(3):308-19. PubMed ID: 16543065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.
    Kollet O; Spiegel A; Peled A; Petit I; Byk T; Hershkoviz R; Guetta E; Barkai G; Nagler A; Lapidot T
    Blood; 2001 May; 97(10):3283-91. PubMed ID: 11342460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined IL-15 and IL-12 drives the generation of CD34
    Cany J; van der Waart AB; Spanholtz J; Tordoir M; Jansen JH; van der Voort R; Schaap NM; Dolstra H
    Oncoimmunology; 2015 Jul; 4(7):e1017701. PubMed ID: 26140247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stem/Stromal Cells Overexpressing CXCR4
    Bidkhori HR; Bahrami AR; Farshchian M; Heirani-Tabasi A; Mirahmadi M; Hasanzadeh H; Ahmadiankia N; Faridhosseini R; Dastpak M; Shabgah AG; Matin MM
    Cell Transplant; 2021; 30():9636897211054498. PubMed ID: 34807749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homing of bone marrow stem cells is differentially activated in ischemic and valvular heart diseases and influenced by beta-blockers.
    Kristocheck M; Dias LD; Ghem C; Eibel B; Kalil RAK; Markoski MM
    J Transl Med; 2018 May; 16(1):133. PubMed ID: 29784000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells.
    Lien CY; Chih-Yuan Ho K; Lee OK; Blunn GW; Su Y
    J Bone Miner Res; 2009 May; 24(5):837-48. PubMed ID: 19113920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.
    Adamiak M; Borkowska S; Wysoczynski M; Suszynska M; Kucia M; Rokosh G; Abdel-Latif A; Ratajczak J; Ratajczak MZ
    Oncotarget; 2015 Aug; 6(22):18819-28. PubMed ID: 26299919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
    Si X; Liu X; Li J; Wu X
    Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model.
    Ng YY; Du Z; Zhang X; Chng WJ; Wang S
    Cancer Gene Ther; 2022 May; 29(5):475-483. PubMed ID: 34471234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.